WVU Medicine St. Joseph’s Hospital is proud to announce the addition of two cutting-edge imaging services: PET/CT and ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

The imaging artificial intelligence developer Quibim has raised $50 million in venture capital funding, to support its work ...

Prostate cancer is rapidly emerging as a significant health challenge in China, with the incidence rate steadily rising.

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and enabling timely interventions.

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

In today’s fast-paced world, men are increasingly seeking solutions to improve their health and well-being, especially when it comes to prostate health. Prosta Renew emerges as a powerful ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.

PSMA-PET is a reference standard examination for patients with prostate cancer, but even using recently introduced digital PET detectors image acquisition with standard field-of-view scanners is still ...

LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO TM a new treatment for advanced-stage prostate ...

In today’s fast-paced world, men often face health challenges that significantly affect their quality of life. One common issue that many men experience is related to prostate health ...